CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion | +8,042 | $0.61 | $5K | 525,746 |
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion | +16,691 | $0.61 | $10K | 542,437 |
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion | +21,827 | $3.37 | $74K | 564,264 |
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion | +20,778 | $3.37 | $70K | 585,042 |
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion | +20,778 | $3.37 | $70K | 605,820 |
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion · Stock Option | −8,042 | 12,063 | ||
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion · Stock Option | −16,691 | 50,072 | ||
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion · Stock Option | −21,827 | 32,918 | ||
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion · Stock Option | −20,778 | 0 | ||
| 2020-01-30 | COHEN MARC A Director | Exercise or conversion · Stock Option | −20,778 | 0 | ||
| 2019-12-30 | Lucchino David L. President and CEO | Exercise or conversion | +36,590 | $0.61 | $22K | 444,441 |
| 2019-12-30 | Lucchino David L. President and CEO | Exercise or conversion | +20,787 | $0.61 | $13K | 465,228 |
| 2019-12-30 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −36,590 | 50,866 | ||
| 2019-12-30 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −20,787 | 310,647 | ||
| 2019-12-03 | Lucchino David L. President and CEO | Grant or award · Stock Option | +96,361 | 96,361 | ||
| 2019-12-03 | COHEN MARC A Director | Grant or award · Stock Option | +20,778 | 20,778 | ||
| 2019-12-03 | Loose Christopher R. Chief Scientific Officer | Grant or award · Stock Option | +64,241 | 64,241 | ||
| 2019-12-03 | LeBel Carl Chief Development Officer | Grant or award · Stock Option | +23,555 | 23,555 | ||
| 2019-10-07 | Alexandria Venture Investments, LLC 10% owner | Conversion | +956,175 | 956,175 | ||
| 2019-10-07 | Alexandria Venture Investments, LLC 10% owner | Conversion · Series A Convertible Preferred Stock | −4,161,974 | 0 |
Page 32 of 34 · 670 trades